Table 3.
Strain | Name | ATCC identifier | Accession | Technology | Last updated |
---|---|---|---|---|---|
H37Rv | F1a[13] | 27294 | CP010329.1 | Pacific Biosciences (P4-C2) | 02/2016 |
H37RvSiena | unspecified | NZ_CP007027.1/CP007027.1 | Illumina | 01/2015 | |
H37RvTMC102 | 27294D-2 | NZ_CP009480.1/CP009480.1 | Illumina | 09/2014 | |
H37RvBroad | unspecified | NC_018143.2/CP003248.2 | 454/Sanger/Illumina | 10/2013 | |
H37Rv [62] | 25618b | NC_000962.3/AL123456.3 | Sanger | 02/2013 | |
H37Ra | H37RaSD [present study] | 25177 | CP016972.1 | Pacific Biosciences (P6-C4) | 08/2016 |
F28a[13] | 25177 | NZ_CP010330.1/CP010330.1 | Pacific Biosciences (P4-C2) | 02/2016 | |
H37RaJH [5] | 25177 | NC_009525.1/CP000611.1 | Sanger | 05/2007 |
Unreferenced entries were direct database submissions and do not have an associated publication
aThe unconventional names for these samples were not explained by Zhu and colleagues [13]. The name F28 in particular is already known from the literature to refer to a family of clinical isolates [63]
bThe ATCC number was unspecified by Cole and colleagues [62]. However, the ATCC catalog entry for this strain identifies it as the source for the sequence